Style | Citing Format |
---|---|
MLA | Shariati A, et al.. "Association Between Colorectal Cancer and Fusobacterium Nucleatum and Bacteroides Fragilis Bacteria in Iranian Patients: A Preliminary Study." Infectious Agents and Cancer, vol. 16, no. 1, 2021, pp. -. |
APA | Shariati A, Razavi S, Ghaznavirad E, Jahanbin B, Akbari A, Norzaee S, Darbansarokhalil D (2021). Association Between Colorectal Cancer and Fusobacterium Nucleatum and Bacteroides Fragilis Bacteria in Iranian Patients: A Preliminary Study. Infectious Agents and Cancer, 16(1), -. |
Chicago | Shariati A, Razavi S, Ghaznavirad E, Jahanbin B, Akbari A, Norzaee S, Darbansarokhalil D. "Association Between Colorectal Cancer and Fusobacterium Nucleatum and Bacteroides Fragilis Bacteria in Iranian Patients: A Preliminary Study." Infectious Agents and Cancer 16, no. 1 (2021): -. |
Harvard | Shariati A et al. (2021) 'Association Between Colorectal Cancer and Fusobacterium Nucleatum and Bacteroides Fragilis Bacteria in Iranian Patients: A Preliminary Study', Infectious Agents and Cancer, 16(1), pp. -. |
Vancouver | Shariati A, Razavi S, Ghaznavirad E, Jahanbin B, Akbari A, Norzaee S, et al.. Association Between Colorectal Cancer and Fusobacterium Nucleatum and Bacteroides Fragilis Bacteria in Iranian Patients: A Preliminary Study. Infectious Agents and Cancer. 2021;16(1):-. |
BibTex | @article{ author = {Shariati A and Razavi S and Ghaznavirad E and Jahanbin B and Akbari A and Norzaee S and Darbansarokhalil D}, title = {Association Between Colorectal Cancer and Fusobacterium Nucleatum and Bacteroides Fragilis Bacteria in Iranian Patients: A Preliminary Study}, journal = {Infectious Agents and Cancer}, volume = {16}, number = {1}, pages = {-}, year = {2021} } |
RIS | TY - JOUR AU - Shariati A AU - Razavi S AU - Ghaznavirad E AU - Jahanbin B AU - Akbari A AU - Norzaee S AU - Darbansarokhalil D TI - Association Between Colorectal Cancer and Fusobacterium Nucleatum and Bacteroides Fragilis Bacteria in Iranian Patients: A Preliminary Study JO - Infectious Agents and Cancer VL - 16 IS - 1 SP - EP - PY - 2021 ER - |